Skip to main content

HPV Vaccination

Volume 611: debated on Thursday 26 May 2016

I am today announcing that a human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM) will start this June.

Since 2008, an HPV vaccination programme for girls has been delivered to help prevent cervical cancer, which also confers a benefit for many boys over the life course.

HPV infection is also associated with ano-genital and oral cancers, and genital warts. In November 2015, the Joint Committee on Vaccination and Immunisation (JCVI) advised that a HPV vaccination programme should be introduced for MSM aged up to 45 years who attend genitourinary medicine (GUM) and HIV clinics, subject to procurement of the HPV vaccine and delivery of the programme at a cost-effective price.

Through this pilot, the HPV vaccine will be offered during existing appointments at selected GUM and HIV clinics in England to test delivery in these settings. Public Health England is in the process of agreeing which GUM and HIV clinics will take part in the pilot. A full roll-out of an HPV vaccination programme for men who have sex with men will be dependent on the progress and outcome of the pilot.